Stelrad Group (SRAD) Competitors GBX 170 0.00 (0.00%) As of 08/22/2025 12:10 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsInsider TradesBuy This Stock SRAD vs. GEN, DOCS, WIX, YOU, CNIC, SLP, NET, ARBB, GVP, and CYNShould you be buying Stelrad Group stock or one of its competitors? The main competitors of Stelrad Group include Genuit Group (GEN), Dr. Martens (DOCS), Wickes Group (WIX), YouGov (YOU), CentralNic Group (CNIC), Sylvania Platinum (SLP), Netcall (NET), Arbuthnot Banking Group (ARBB), Gabelli Value Plus+ Trust (GVP), and CQS Natural Resources Growth and Income (CYN). These companies are all part of the "computer software" industry. Stelrad Group vs. Its Competitors Genuit Group Dr. Martens Wickes Group YouGov CentralNic Group Sylvania Platinum Netcall Arbuthnot Banking Group Gabelli Value Plus+ Trust CQS Natural Resources Growth and Income Genuit Group (LON:GEN) and Stelrad Group (LON:SRAD) are both small-cap industrials companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, media sentiment, analyst recommendations, institutional ownership, earnings and dividends. Do institutionals and insiders hold more shares of GEN or SRAD? 82.1% of Genuit Group shares are owned by institutional investors. Comparatively, 35.5% of Stelrad Group shares are owned by institutional investors. 2.5% of Genuit Group shares are owned by insiders. Comparatively, 64.4% of Stelrad Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is GEN or SRAD a better dividend stock? Genuit Group pays an annual dividend of GBX 12 per share and has a dividend yield of 3.3%. Stelrad Group pays an annual dividend of GBX 8 per share and has a dividend yield of 4.7%. Genuit Group pays out 125.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Stelrad Group pays out 68.7% of its earnings in the form of a dividend. Stelrad Group is clearly the better dividend stock, given its higher yield and lower payout ratio. Do analysts recommend GEN or SRAD? Genuit Group currently has a consensus target price of GBX 506.67, suggesting a potential upside of 38.06%. Stelrad Group has a consensus target price of GBX 200, suggesting a potential upside of 17.65%. Given Genuit Group's higher probable upside, equities research analysts plainly believe Genuit Group is more favorable than Stelrad Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genuit Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Stelrad Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility and risk, GEN or SRAD? Genuit Group has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Stelrad Group has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500. Does the media refer more to GEN or SRAD? In the previous week, Genuit Group had 1 more articles in the media than Stelrad Group. MarketBeat recorded 1 mentions for Genuit Group and 0 mentions for Stelrad Group. Genuit Group's average media sentiment score of 0.18 beat Stelrad Group's score of 0.00 indicating that Genuit Group is being referred to more favorably in the media. Company Overall Sentiment Genuit Group Neutral Stelrad Group Neutral Which has preferable valuation & earnings, GEN or SRAD? Genuit Group has higher revenue and earnings than Stelrad Group. Stelrad Group is trading at a lower price-to-earnings ratio than Genuit Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenuit Group£553.28M1.65£23.57M£9.5338.51Stelrad Group£306.97M0.74£16.13M£11.6414.61 Is GEN or SRAD more profitable? Stelrad Group has a net margin of 5.25% compared to Genuit Group's net margin of 4.26%. Stelrad Group's return on equity of 28.08% beat Genuit Group's return on equity.Company Net Margins Return on Equity Return on Assets Genuit Group4.26% 3.74% 4.59% Stelrad Group 5.25%28.08%7.46% SummaryGenuit Group beats Stelrad Group on 10 of the 17 factors compared between the two stocks. Get Stelrad Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SRAD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRAD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRAD vs. The Competition Export to ExcelMetricStelrad GroupBuilding Products & Equipment IndustryIndustrials SectorLON ExchangeMarket Cap£225.85M£3.57B£7.65B£3.22BDividend Yield5.31%3.03%4.56%5.04%P/E Ratio14.6156.9126.14164.70Price / Sales0.7486.4399.63310,110.48Price / Cash12.5517.0728.3927.93Price / Book3.941.764.095.91Net Income£16.13M£18.85B£796.69M£5.89B7 Day Performance3.03%-0.36%0.63%49.50%1 Month Performance-0.41%-4.31%0.50%56.36%1 Year Performance18.06%1.03%26.73%136.20% Stelrad Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRADStelrad Group2.4405 of 5 starsGBX 170flatGBX 200+17.6%+14.9%£225.85M£306.97M14.612,960GENGenuit Group2.2393 of 5 starsGBX 359-1.5%GBX 506.67+41.1%-20.3%£890.43M£553.28M37.672,700Gap DownDOCSDr. Martens3.6814 of 5 starsGBX 87.95+0.3%GBX 6,000+6,722.1%+21.7%£853.79M£874.20M12.47890News CoverageDividend CutWIXWickes Group2.2375 of 5 starsGBX 219+0.9%GBX 215-1.8%+39.0%£518.53M£1.45B17.715,930News CoveragePositive NewsYOUYouGov2.9232 of 5 starsGBX 338+1.0%GBX 662.50+96.0%-32.9%£395.51M£335.28M-172.261,820Gap DownCNICCentralNic GroupN/AN/AN/AN/A£339.82M£790.04M-12,660.00100SLPSylvania Platinum3.0955 of 5 starsGBX 74.50-0.7%GBX 93+24.8%+35.1%£240.43M£99.97M34.91160NETNetcall1.7072 of 5 starsGBX 120-0.8%GBX 138.33+15.3%+32.3%£198.35M£39.16M33.793,220ARBBArbuthnot Banking GroupN/AGBX 1,010.55+0.6%N/A+7.3%£163.57M£239.83M5.35799Gap UpHigh Trading VolumeGVPGabelli Value Plus+ TrustN/AN/AN/AN/A£155.29MN/A0.00310Gap DownCYNCQS Natural Resources Growth and IncomeN/AGBX 221flatN/A+30.5%£138.97M£12.63M15.7140 Related Companies and Tools Related Companies Genuit Group Alternatives Dr. Martens Alternatives Wickes Group Alternatives YouGov Alternatives CentralNic Group Alternatives Sylvania Platinum Alternatives Netcall Alternatives Arbuthnot Banking Group Alternatives Gabelli Value Plus+ Trust Alternatives CQS Natural Resources Growth and Income Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SRAD) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stelrad Group PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Stelrad Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.